Drug to treat advanced ovarian cancer gets early FDA approval
Along with ovarian cancer patients, the clinical trial included those with fallopian tube peritoneal cancers. "Each year over 14,000 women die of ovarian cancer," the highest for any gynecologic cancer, he said. About 22,000 women develop ovarian cancer annually in the United States. BRCA mutations predispose carriers to breast, ovarian and other cancers. For women without BRCA mutations, progression-free survival was 9.3 months compared with 3.9 months for those on placebo.
Study finds 12 genetic variants that raise the risk of ovarian cancer
A large genetic study has identified 12 new variants commonly associated with the risk of epithelial Ovarian cancer. Epithelial ovarian cancer (EOC) is the most common type of ovarian cancer. The genes we inherit affect our chances of developing ovarian cancer, and a new genomic study identifies 12 genetic variants associated with the risk. Ovarian cancer is a common form of cancer and a leading cause of cancer death among women. "We know that a woman's genetic makeup accounts for about one third of her risk of developing ovarian cancer.collected by :Lucy William
No comments:
Post a Comment